GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beamtree Holdings Ltd (ASX:BMT) » Definitions » Notes Receivable

Beamtree Holdings (ASX:BMT) Notes Receivable : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Beamtree Holdings Notes Receivable?

Beamtree Holdings's Notes Receivable for the quarter that ended in Dec. 2023 was A$0.00 Mil.


Beamtree Holdings Notes Receivable Historical Data

The historical data trend for Beamtree Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beamtree Holdings Notes Receivable Chart

Beamtree Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Notes Receivable
- - - -

Beamtree Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Beamtree Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Beamtree Holdings Notes Receivable Related Terms

Thank you for viewing the detailed overview of Beamtree Holdings's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Beamtree Holdings (ASX:BMT) Business Description

Traded in Other Exchanges
N/A
Address
16 Eveleigh Street, Level 1, Redfern, NSW, AUS, 2016
Beamtree Holdings Ltd is engaged in the development of an integrated platform for information and knowledge management, empowering a learning health system. Beamtree, incorporating AI and ML is providing end-to-end support from the moment of data collection and classification through quality and performance benchmarking to clinical decision support at point of care.

Beamtree Holdings (ASX:BMT) Headlines

No Headlines